Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation
Ivan Pašić, Jeffrey H. Lipton, Dennis Dong Hwan Kim, Auro Viswabandya, Rajat Kumar, Wilson Lam, Arjun Law, Jonas Mattsson, Fotios V. Michelis
Topics & Concepts
MedicineAnti-thymocyte globulinInternal medicineCumulative incidenceIncidence (geometry)CyclophosphamideGraft-versus-host diseaseGastroenterologyConfidence intervalHematopoietic stem cell transplantationTransplantationHematologyImmunologyChemotherapyPhysicsOpticsHematopoietic Stem Cell TransplantationChildhood Cancer Survivors' Quality of LifeAcute Lymphoblastic Leukemia research